BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 16289417)

  • 1. Targeting acetylcholinesterase to the neuromuscular synapse.
    Rotundo RL; Rossi SG; Kimbell LM; Ruiz C; Marrero E
    Chem Biol Interact; 2005 Dec; 157-158():15-21. PubMed ID: 16289417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction.
    Cartaud A; Strochlic L; Guerra M; Blanchard B; Lambergeon M; Krejci E; Cartaud J; Legay C
    J Cell Biol; 2004 May; 165(4):505-15. PubMed ID: 15159418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and localization of acetylcholinesterase at the neuromuscular junction.
    Rotundo RL
    J Neurocytol; 2003; 32(5-8):743-66. PubMed ID: 15034265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis.
    Ohno K; Ito M; Kawakami Y; Krejci E; Engel AG
    Chem Biol Interact; 2013 Mar; 203(1):335-40. PubMed ID: 22981737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan.
    Peng HB; Xie H; Rossi SG; Rotundo RL
    J Cell Biol; 1999 May; 145(4):911-21. PubMed ID: 10330416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional organization of synaptic acetylcholinesterase.
    Aldunate R; Casar JC; Brandan E; Inestrosa NC
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):96-104. PubMed ID: 15572165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.
    Arikawa-Hirasawa E; Rossi SG; Rotundo RL; Yamada Y
    Nat Neurosci; 2002 Feb; 5(2):119-23. PubMed ID: 11802174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse.
    Kimbell LM; Ohno K; Engel AG; Rotundo RL
    J Biol Chem; 2004 Mar; 279(12):10997-1005. PubMed ID: 14702351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly and regulation of acetylcholinesterase at the vertebrate neuromuscular junction.
    Rotundo RL; Ruiz CA; Marrero E; Kimbell LM; Rossi SG; Rosenberry T; Darr A; Tsoulfas P
    Chem Biol Interact; 2008 Sep; 175(1-3):26-9. PubMed ID: 18599029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
    Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
    FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholinesterase and molecular interactions at the neuromuscular junction.
    Guerra M; Cartaud A; Cartaud J; Legay C
    Chem Biol Interact; 2005 Dec; 157-158():57-61. PubMed ID: 16289501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ColQ controls postsynaptic differentiation at the neuromuscular junction.
    Sigoillot SM; Bourgeois F; Lambergeon M; Strochlic L; Legay C
    J Neurosci; 2010 Jan; 30(1):13-23. PubMed ID: 20053883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina.
    Arredondo J; Lara M; Ng F; Gochez DA; Lee DC; Logia SP; Nguyen J; Maselli RA
    Hum Genet; 2014 May; 133(5):599-616. PubMed ID: 24281389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinesterases and the basal lamina at vertebrate neuromuscular junctions.
    Massoulié J; Millard CB
    Curr Opin Pharmacol; 2009 Jun; 9(3):316-25. PubMed ID: 19423392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane mechanisms in the assembly of the postsynaptic apparatus at the neuromuscular junction.
    Geng L; Qian YK; Madhavan R; Peng HB
    Chem Biol Interact; 2008 Sep; 175(1-3):108-12. PubMed ID: 18513712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental consequences of the ColQ/MuSK interactions.
    Karmouch J; Dobbertin A; Sigoillot S; Legay C
    Chem Biol Interact; 2013 Mar; 203(1):287-91. PubMed ID: 23089045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The collagen ColQ binds to LRP4 and regulates the activation of the Muscle-Specific Kinase-LRP4 receptor complex by agrin at the neuromuscular junction.
    Uyen Dao TM; Barbeau S; Messéant J; Della-Gaspera B; Bouceba T; Semprez F; Legay C; Dobbertin A
    J Biol Chem; 2023 Aug; 299(8):104962. PubMed ID: 37356721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.
    Nakata T; Ito M; Azuma Y; Otsuka K; Noguchi Y; Komaki H; Okumura A; Shiraishi K; Masuda A; Natsume J; Kojima S; Ohno K
    Hum Mutat; 2013 Jul; 34(7):997-1004. PubMed ID: 23553736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.
    Otsuka K; Ito M; Ohkawara B; Masuda A; Kawakami Y; Sahashi K; Nishida H; Mabuchi N; Takano A; Engel AG; Ohno K
    Sci Rep; 2015 Sep; 5():13928. PubMed ID: 26355076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane.
    Jacobson C; Côté PD; Rossi SG; Rotundo RL; Carbonetto S
    J Cell Biol; 2001 Feb; 152(3):435-50. PubMed ID: 11157973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.